University of Rochester - Wilmot Cancer Institute — Rochester, New York

University of Rochester - Wilmot Cancer Institute is a clinical research site located in Rochester, New York, United States 14642.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Rochester - Wilmot Cancer Institute has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: HER2-negative Breast Cancer, Urinary Bladder Neoplasms, Neoplasm Metastasis.

Sponsors: NSABP Foundation Inc, Eli Lilly and Company, University of Rochester.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Rochester - Wilmot Cancer Institute?

University of Rochester - Wilmot Cancer Institute has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Rochester - Wilmot Cancer Institute conducted?

University of Rochester - Wilmot Cancer Institute has 5 clinical trials on record, with 3 currently active. Their work covers HER2-negative Breast Cancer, Urinary Bladder Neoplasms, Neoplasm Metastasis.

Is University of Rochester - Wilmot Cancer Institute accredited by Crixeo Health?

Yes — University of Rochester - Wilmot Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Rochester - Wilmot Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.